A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
Conditions
- Carcinoma
- Non Small Cell Lung
Interventions
- DRUG: Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)
- DRUG: Placebo
- DRUG: Docetaxel (Taxotere®)
- DRUG: Dexamethasone (pre- and post-medication for docetaxel)
Sponsor
Sanofi
Collaborators